Chen Yi-Ren, Zhang Ya-Da, Zhang Wei, Tang Bin-Qing
Department of Pneumology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, No.274 of Zhijiang Middle Road, Jing'an District, Shanghai, 200071, China.
Department of Pulmonary Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, 185 Pu'an Road, Huangpu District, Shanghai, 201203, China.
Hereditas. 2025 Jul 2;162(1):120. doi: 10.1186/s41065-025-00490-9.
The aim of this study is to identify the principal active components of scorpion and centipede-derived traditional Chinese medicine (TCM) ingredients using network pharmacology and explore their mechanisms of action in the treatment of asthma.
The chemical constituents and target information pertaining to scorpion and centipede-derived TCM components were obtained from the Traditional Chinese Medicine System Pharmacology (TCMSP) database and an herbal database. Asthma-related target genes were retrieved from the GeneCards and the Online Mendelian Inheritance in Man (OMIM) databases. The "component-target" network was constructed with the identified target genes using "Cytoscape 3.9.2" software, and the protein-protein interaction (PPI) network was generated in conjunction with the String database to further identify the core targets. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and gene ontology (GO) functional enrichment analysis were carried out on the targets associated with scorpion and centipede-derived TCM components. Molecular docking was subsequently performed using Autodock Vina software to validate the results. Asthma mouse model was established, and mouse lung tissues were collected for histopathological examination. The levels of TP53, HSP90AA1, and IL-17 mRNA in the mouse lung tissues were evaluated.
A total of 11 active components met the screening conditions, including 4 centipede-derived components and 7 scorpion-derived components. The key components identified included histamine, L-histidine, stearin, cholesteryl ferulate, and cholesterol, among others. Targets with degree values ≥ 16 included TP53, HSP90AA1, HSP90AB1, steroid receptor coactivator (SRC), epidermal growth factor receptor (EGFR), estrogen receptor 1 (ESR1), mitogen-activated protein kinase 1 (MAPK1), mitogen-activated protein kinase 3 (MAPK3), and histone deacetylase 1 (HDAC1). The pathways involved comprised calcium signaling, estrogen signaling, arachidonic acid metabolism, inflammatory mediator and transient receptor potential (TRP) signaling, vascular smooth muscle contraction, thyroid hormone signaling, sphingolipid signaling, IL-17 signaling, insulin resistance, and human cytomegalovirus infection pathways. Furthermore, the mouse experiments showed that SC improved inflammatory cell infiltration and mucus secretion in mouse lung tissues and significantly suppressed the expression of TP53, HSP90AA1, and IL-17 mRNA (all p < 0.05).
Scorpion and centipede-derived active components may exert therapeutic effects in asthma treatment through potential targets such as TP53, HSP90AA1, HSP90AB1, SRC, EGFR, ESR1, MAPK1, MAPK3, and HDAC1.
本研究旨在利用网络药理学确定蝎和蜈蚣来源的中药成分的主要活性成分,并探讨其治疗哮喘的作用机制。
从中药系统药理学(TCMSP)数据库和一个草药数据库中获取与蝎和蜈蚣来源的中药成分相关的化学成分和靶点信息。从基因卡片(GeneCards)和人类孟德尔遗传在线(OMIM)数据库中检索哮喘相关的靶基因。使用“Cytoscape 3.9.2”软件,将鉴定出的靶基因构建“成分-靶点”网络,并结合String数据库生成蛋白质-蛋白质相互作用(PPI)网络,以进一步确定核心靶点。对与蝎和蜈蚣来源的中药成分相关的靶点进行京都基因与基因组百科全书(KEGG)通路富集分析和基因本体(GO)功能富集分析。随后使用Autodock Vina软件进行分子对接以验证结果。建立哮喘小鼠模型,并收集小鼠肺组织进行组织病理学检查。评估小鼠肺组织中TP53、HSP90AA1和IL-17 mRNA的水平。
共有11种活性成分符合筛选条件,其中包括4种蜈蚣来源的成分和7种蝎来源的成分。鉴定出的关键成分包括组胺、L-组氨酸、硬脂酸、阿魏酸胆固醇酯和胆固醇等。度值≥16的靶点包括TP53、HSP90AA1、HSP90AB1、类固醇受体共激活因子(SRC)、表皮生长因子受体(EGFR)、雌激素受体1(ESR1)、丝裂原活化蛋白激酶1(MAPK1)、丝裂原活化蛋白激酶3(MAPK3)和组蛋白去乙酰化酶1(HDAC1)。涉及的通路包括钙信号通路、雌激素信号通路、花生四烯酸代谢、炎症介质和瞬时受体电位(TRP)信号通路、血管平滑肌收缩、甲状腺激素信号通路、鞘脂信号通路、IL-17信号通路、胰岛素抵抗和人巨细胞病毒感染通路。此外,小鼠实验表明,蝎和蜈蚣提取物改善了小鼠肺组织中的炎性细胞浸润和黏液分泌,并显著抑制了TP53、HSP90AA1和IL-17 mRNA的表达(均p<0.05)。
蝎和蜈蚣来源的活性成分可能通过TP53、HSP90AA1、HSP90AB1、SRC、EGFR、ESR1、MAPK1、MAPK3和HDAC1等潜在靶点在哮喘治疗中发挥治疗作用。